APLT Applied Therapeutics Inc

USD 5.16 0.00 0
Icon

Applied Therapeutics Inc (APLT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.16

0.00 (0.00)%

USD 0.55B

0.66M

USD 11.43(+121.48%)

USD 3.00 (-41.86%)

Icon

APLT

Applied Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 5.16
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.55B

USD 3.00 (-41.86%)

USD 5.16

Applied Therapeutics Inc (APLT) Stock Forecast

Show ratings and price targets of :
USD 11.43
(+121.48%)

Based on the Applied Therapeutics Inc stock forecast from 5 analysts, the average analyst target price for Applied Therapeutics Inc is USD 11.43 over the next 12 months. Applied Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Applied Therapeutics Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Applied Therapeutics Inc’s stock price was USD 5.16. Applied Therapeutics Inc’s stock price has changed by -10.73% over the past week, -15.55% over the past month and +516.49% over the last year.

No recent analyst target price found for Applied Therapeutics Inc
No recent average analyst rating found for Applied Therapeutics Inc

Company Overview Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is...Read More

545 Fifth Avenue, New York, NY, United States, 10017

25

December

USD

USA

Adjusted Closing Price for Applied Therapeutics Inc (APLT)

Loading...

Unadjusted Closing Price for Applied Therapeutics Inc (APLT)

Loading...

Share Trading Volume for Applied Therapeutics Inc Shares

Loading...

Compare Performance of Applied Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APLT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Applied Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD107.38B 29.93 21.06

ETFs Containing APLT

Symbol Name APLT's Weight Expense Ratio Price(Change) Market Cap
SURI
Simplify Propel Opportuni.. 7.01 % 2.51 % 0.00 (0.00%) USD0.12B

Frequently Asked Questions About Applied Therapeutics Inc (APLT) Stock

Based on ratings from 5 analysts Applied Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 7 buy, sell and hold ratings.

Unfortunately we do not have enough data on APLT's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for APLT is USD 11.43 over the next 12 months. The maximum analyst target price is USD 13 while the minimum anlayst target price is USD 7.

Unfortunately we do not have enough data on APLT's stock to indicate if its overvalued.

The last closing price of APLT's stock was USD 5.16.

The most recent market capitalization for APLT is USD 0.55B.

Based on targets from 5 analysts, the average taret price for APLT is projected at USD 11.43 over the next 12 months. This means that APLT's stock price may go up by +121.48% over the next 12 months.

Following are ETFs with the highest allocation to Applied Therapeutics Inc's stock :

SURI

As per our most recent records Applied Therapeutics Inc has 25 Employees.

Applied Therapeutics Inc's registered address is 545 Fifth Avenue, New York, NY, United States, 10017. You can get more information about it from Applied Therapeutics Inc's website at https://www.appliedtherapeutics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...